✦ LIBER ✦

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

✍ Scribed by George C Ebers

Book ID: 117311264
Publisher: The Lancet
Year: 1998
Tongue: English
Weight: 97 KB
Volume: 352
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(98)03334-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Firategrast for relapsing remitting mult

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial

✍ David H Miller; Thomas Weber; Richard Grove; Claire Wardell; Joseph Horrigan; Ol 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 267 KB

Methylprednisolone in combination with i

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

✍ Mads Ravnborg; Per Soelberg Sørensen; Magnus Andersson; Elisabeth G Celius; Pete 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 374 KB

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp

Neuropsychological performance during a

Neuropsychological performance during a double-blind, placebo-controlled trial of copolymer-1 in relapsing-remitting multiple sclerosis

✍ M. Grossman; K. Onishi; H. Thompson; M. D'Esposito; C. Armstrong; J. Cohen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Intravenous immunoglobulin treatment in

Intravenous immunoglobulin treatment in relapsing-remitting multiple sclerosis: A randomized, double-blind multicenter, placebo-controlled trial

✍ A. Achiron; R. Gilad; S. Hassin; Y. Barak; U. Gabbay; I. Ziv; Y. Goldhamer; E. M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Efficacy and safety of oral fumarate in

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ Ludwig Kappos; Ralf Gold; David H Miller; David G MacManus; Eva Havrdova; Volker 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 209 KB